Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Biomedicines|December 23, 2022
Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort StudyKoji Iinuma, Risa Tomioka-Inagawa, Koji Kameyama, et al.Current Oncology (Toronto, Ont.)|August 25, 2022
Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell CancerMakoto Kawase, Kimiaki Takagi, Kei Kawada, et al.Cancers|February 11, 2023
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort StudyKoji Iinuma, Toyohiro Yamada, Koji Kameyama, et al.Cancers|August 10, 2024
Oncologic Outcomes of Patients with Immune Checkpoint Inhibitor Resistant Urothelial Carcinoma Treated with Enfortumab Vedotin and the Impact of Neutrophil-to-Lymphocyte Ratio and Dysgeusia on Overall Survival: A Retrospective Multicenter Cohort Study in JapanKeita Nakane, Kazuki Taniguchi, Minori Nezasa, et al.Biomedicines|September 23, 2022
Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort StudyToyohiro Yamada, Keita Nakane, Torai Enomoto, et al.Journal of Internal Medicine|September 22, 2025
Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort studyShogo Matsuda, Takuya Kotani, Daisuke Nishioka, et al.Modern Rheumatology|December 12, 2025
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: a multicentre REVEAL cohort studyHirofumi Miyake, Ayana Okazaki, Shogo Matsuda, et al.Biomedicines|July 27, 2022
The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial CarcinomaRisa Tomioka-Inagawa, Keita Nakane, Torai Enomoto, et al.Current Oncology (Toronto, Ont.)|May 24, 2024
Discrepancy in the Location of Prostate Cancer Indicated on Biparametric Magnetic Resonance Imaging and Pathologically Diagnosed Using Surgical SpecimensMasayuki Tomioka, Keita Nakane, Makoto Kawase, et al.Rheumatology (Oxford, England)|March 10, 2026
Renal outcomes in ANCA-associated vasculitis without clinically apparent kidney involvement: a multicentre REVEAL cohort studyTomoki Taniguchi, Ryosuke Hiwa, Shingo Iwasaka, et al.Pageof 6